Essex Investment Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$66 Hold
11
﹤0.01% 305
2025
Q4
$79 Hold
11
﹤0.01% 306
2025
Q3
$117 Hold
11
﹤0.01% 299
2025
Q2
$106 Hold
11
﹤0.01% 298
2025
Q1
$164 Hold
11
﹤0.01% 303
2024
Q4
$164 Sell
11
-85
-89% -$1.39K ﹤0.01% 306
2024
Q3
$1.84K Hold
96
﹤0.01% 300
2024
Q2
$1.99K Hold
96
﹤0.01% 300
2024
Q1
$1.8K Sell
96
-8
-8% -$137 ﹤0.01% 303
2023
Q4
$1.5K Hold
104
﹤0.01% 313
2023
Q3
$1.8K Sell
104
-5
-5% -$104 ﹤0.01% 355
2023
Q2
$2.27K Hold
109
﹤0.01% 366
2023
Q1
$2.56K Hold
109
﹤0.01% 379
2022
Q4
$3K Hold
109
﹤0.01% 390
2022
Q3
$3K Hold
109
﹤0.01% 406
2022
Q2
$4K Hold
109
﹤0.01% 414
2022
Q1
$4K Sell
109
-11
-9% -$376 ﹤0.01% 385
2021
Q4
$4K Hold
120
﹤0.01% 397
2021
Q3
$4K Hold
120
﹤0.01% 410
2021
Q2
$4K Buy
+120
New +$3.95K ﹤0.01% 410

Other funds holding OGN

Essex Investment Management's OGN Position: Q1 2026 in Review

Essex Investment Management held its Organon & Co (OGN) position steady in Q1 2026 at 11 shares worth $66. The position accounts for ﹤0.01% of the portfolio, ranked #305.

Essex Investment Management first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $4K in Q2 2022. 606 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Essex Investment Management held 11 shares of Organon & Co worth $66 as of Q1 2026.
  • Essex Investment Management left its Organon & Co share count unchanged in Q1 2026.
  • Organon & Co made up ﹤0.01% of Essex Investment Management's portfolio in Q1 2026, its #305 holding.
  • Essex Investment Management first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
  • Essex Investment Management's Organon & Co position peaked at $4K in Q2 2022.
  • 606 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Essex Investment Management's 13F filing for Q1 2026, filed 11 May 2026.